药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
4-Bromo-2,5-dimethoxyamphetamine
Magnesium hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Magnesium lactate
Magnesium lactate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Magnesium levulinate
Magnesium levulinate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Magnesium orotate
Magnesium orotate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Magnesium gluconate
Magnesium gluconate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Magnesium aspartate
Magnesium aspartate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Magnesium citrate
Magnesium citrate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Talc
Talc can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Magnesium chloride
Magnesium chloride can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Magaldrate
Magaldrate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Difluocortolone
The risk or severity of tendinopathy can be increased when Difluocortolone is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Prednisolone acetate
The risk or severity of tendinopathy can be increased when Prednisolone acetate is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Clobetasol
The risk or severity of tendinopathy can be increased when Clobetasol is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Fluocortolone
The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Hydrocortisone butyrate
The risk or severity of tendinopathy can be increased when Hydrocortisone butyrate is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Hydrocortisone succinate
The risk or severity of tendinopathy can be increased when Hydrocortisone succinate is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Hydrocortisone cypionate
The risk or severity of tendinopathy can be increased when Hydrocortisone cypionate is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Hydrocortisone acetate
The risk or severity of tendinopathy can be increased when Hydrocortisone acetate is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Mometasone furoate
The risk or severity of tendinopathy can be increased when Mometasone furoate is combined with Delafloxacin.